fda bpc 157 safety concerns compounding Heal or Harm: Body Protective Compound-157 in the Gray Zone FDA mulls compounding for peptides
Description
PLoS One 9 , e93605 (2014)
Not in ordinary personal research terms
[DOI] [PubMed] [Google Scholar] 166
A retest now of serum B12, once on weekly injections, will probably be unhelpful as it will be high either way
Lets explore how people are accessing this stuff
Please ensure your delivery details are accurate to avoid delays
